Directory → Immunotropona funds → Immunomodulators → Immunomax
This page is translated automatically with a help of Google Translate

Immunomax

See also Aminobenzoic acid

Roman name

Immunomax

The composition and the form of

Powder liofilizirovanny preparation injection solution for the m-the one fl.kisly peptidoglican with molecular weight 1000-40000 SD-100 ED- 200 Edvo vial with the solvent in the ampoule, and the gun shows; In the paper cartons 1, or 3 bottle or a box 30 bottles.

Characteristics

Sour peptidoglican with molecular weight 1000-40000 SD.

Pharmacokinetics

Not reviewed at the peptidoglicanova nature of the drug, and very small doses operating.

Farmakodinamika

Иммунофармакологичес кие mechanisms of the drug is that it activates the immune levels of protection :-cells, which in a couple of hours after the exposure preparation heavily expressiruut activation molecule CD69; zitolitical Nk-kletok activity increased 3 times; - circulating monocita 2-4 h after activation product beginning secretirovti zitokin : interleykin-8, interleikin-1-beta and necrosis factor alpha tumors; - neutrophil granulozita activated as a result of activation of monocytes and direct action at the neutrophil granulozita mean no; secretiruemy monocitami interleykin-8 was increased neitrofilnykh granulozitov that is evident within 24 h after exposure preparation; - Fabric macrofagi, resulting in a change in the morphology of these cells increased production methods substances Climate 5'-nukleotidaza activity; Education antibodies against antigens alien soluble and �орпускулярных.Усилив ает protection against infection by viruses (HPV virus rights, a simple virus herpes, parvovirus, the virus plague carnivores and others), or bacteria (Escherichia coli, Salmonella, Staphylococcus, chlamydia, mikoplazma, ureaplazma and others). This action is in adults and newborns with a drug in various ways : in / m, / in, vnutribruchinno, inside.

Indications

Correction weakened immunity; Treatment of pathological conditions (HPV, papilloma, dysplasia and others), caused by human papillomavirus; Treatment of infection by with herpes simplex virus, chlamydia, mikoplazma, ureaplazma, other bacteria and viruses.

Pregnancy and lactation

There is no data on the effects of the drug on pregnant women. As in the case of other property, it should not be used during pregnancy unless benefits the patient does not exceed the potential risk to the fetus. Not that nursing mothers.

Contraindications

Hypersensitivity to the drug; Children up to age 12 years.

Side-Effects

Not found.

Patient interaction

Not described.

Storage conditions

The temperature 4-8 ° C

Shelf life

2

The registration

001919/02-2002

The drug forms

Liofilizirovanny powder white.

All products of this group